1
|
Su J, Wang DS, Hu GX, Liu YY, Hu M, Chen Y, Wang QQ, Yan RC, Wu Y, Li YJ, Ma K, Qi YY, Ding LF, Wu XD. Anti-pancreatic cancer activity of cassane diterpenoids isolated from the seeds of Caesalpinia sappan mediated by autophagy activation via ROS/AMPK/mTORC1 pathway. PHYTOCHEMISTRY 2024; 222:114105. [PMID: 38657886 DOI: 10.1016/j.phytochem.2024.114105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2024] [Revised: 04/17/2024] [Accepted: 04/21/2024] [Indexed: 04/26/2024]
Abstract
Three undescribed cassane diterpenoids, caesalpanins D-F (1-3), and seven known ones were isolated from the seeds of Caesalpinia sappan. Structures and absolute configurations of 1-3 were elucidated based on the extensive spectroscopic analysis, single-crystal X-ray diffraction analysis, and ECD calculations. Structurally, compound 1 was the first example of 18-norcassane diterpenoid and 2 was a rare 20-norcassane diterpenoid having an unusual five-membered oxygen bridge between C-10/C-18. The anti-proliferative activity of 1, 3, and 4-10 against PANC-1 cells (pancreatic ductal adenocarcinoma cell line) was evaluated, and phanginin H (4) was found to exhibit anti-cancer activity with IC50 value of 18.13 ± 0.63 μM. Compound 4 inhibited PANC-1 cell growth by arresting the cell cycle at G2/M phase via regulation of cyclin-dependent kinases, and the self-renewal and metastasis of PANC-1 cells by suppressing cancer cell stemness. Furthermore, compound 4 induced ROS generation and subsequently activated autophagy, which was demonstrated by the formation of autophagic vacuoles and dynamic change of autophagic flux. The induced ROS accumulation resulted in AMPK activation and subsequently regulation of mTORC1 activity and ULK phosphorylation, indicating that 4 triggered autophagy through ROS/AMPK/mTORC1 pathway. These findings suggested that 4 might potentially be an autophagy inducer for the therapy of pancreatic cancer.
Collapse
Affiliation(s)
- Jia Su
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, PR China
| | - De-Sheng Wang
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China; School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, PR China
| | - Guo-Xian Hu
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, PR China
| | - Yu-Yao Liu
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, PR China
| | - Ming Hu
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China
| | - Ya Chen
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, PR China
| | - Qi-Qi Wang
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, PR China
| | - Run-Cheng Yan
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China
| | - Yun Wu
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China
| | - Yong-Jiao Li
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China
| | - Ke Ma
- Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, 650011, PR China
| | - Yan-Yan Qi
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China.
| | - Lin-Fen Ding
- School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, PR China; College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, PR China.
| | - Xing-De Wu
- Key Laboratory of Ethnic Medicine Resource Chemistry, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, 650504, PR China.
| |
Collapse
|
2
|
Ma J, Li Q, Wang T, Lu H, Liu J, Cai R, Zhang Y, Zhang J, Xie X, Su J. A comprehensive review of Shengdeng in Tibetan medicine: textual research, herbal and botanical distribution, traditional uses, phytochemistry, and pharmacology. Front Pharmacol 2023; 14:1303902. [PMID: 38174223 PMCID: PMC10762315 DOI: 10.3389/fphar.2023.1303902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 11/13/2023] [Indexed: 01/05/2024] Open
Abstract
"Shengdeng", a group of Tibetan medicines with diverse biological origins, has long been utilized in Tibet for the treatment of rheumatoid arthritis. It showcases remarkable efficacy in alleviating rheumatism, reducing swelling, and relieving pain. This study aimed to clarify the plant species used as "Shengdeng" and summarize their botanical distribution, traditional uses, phytochemistry, and pharmacology to promote its utilization and development. "Shengdeng" is derived from a remarkable collection of 14 plant species belonging to six distinct families. Extensive phytochemical investigations have led to the identification of 355 chemical constituents within "Shengdeng". Pharmacological studies conducted on "Shengdeng" have revealed a wide range of beneficial properties, including antioxidant, anticancer, antimicrobial, antiviral, antiparasitic, anti-inflammatory, and anti-arthritic activities. Notably, flavonoids and triterpenoids emerge as the predominant groups among these constituents, contributing to the therapeutic potential and diverse applications of "Shengdeng". The present review provides a concise summary of the recent advancements in textual research concerning the herbal and botanical distribution, traditional uses, phytochemistry, and pharmacological activities of "Shengdeng". It is crucial to note that future research on "Shengdeng" should prioritize the analysis of its active ingredients and the establishment of rigorous quality standards. These aspects are essential for ensuring consistency, efficacy, and safety in its clinical application.
Collapse
Affiliation(s)
- Jing Ma
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Qiuyue Li
- Pharmacy Intravenous Admixture Service of the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China
| | - Ting Wang
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Hanyu Lu
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jia Liu
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Rangji Cai
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yi Zhang
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jing Zhang
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Xiaolong Xie
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jinsong Su
- Ethnic Medicine Academic Heritage Innovation Research Center, Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|
3
|
Jin Y, Wang M, Yan YF, Zhang XX, Li XZ, Gao HY. Bridged cassane derivatives from the seeds of Caesalpinia sappan L. and their cytotoxic activities. PHYTOCHEMISTRY 2022; 197:113111. [PMID: 35124529 DOI: 10.1016/j.phytochem.2022.113111] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 01/19/2022] [Accepted: 01/20/2022] [Indexed: 06/14/2023]
Abstract
Two undescribed nitrogen bridged cassane alkaloids (caesanamides A-B) and five undescribed oxygen bridged cassane diterpenoids (caesalpinins JA-JE), together with six known analogs, were isolated and identified from the seeds of Caesalpinia sappan. Their structures, including the absolute configurations, were unequivocally elucidated by the analysis of comprehensive spectroscopic data, ECD calculations, single-crystal X-ray diffraction and the CASE algorithm. Among them, caesanamides A and B represent the first examples of cassane alkaloids bearing unique ring systems of an amide bridge between C-19/C-20 incorporating a 1,3-oxazolidine (6/6/6/5/6/5) or a 7-one-1,3-oxazepine (6/6/6/5/6/7). Caesalpinin JA is an A/B cis-20-norcassane diterpenoid with a rare five-membered oxygen bridge between C-10/C-18. Biological evaluation showed that cassane alkaloids exhibited significant cytotoxicity against HepG2 cells with IC50 values of 13.48 ± 1.07 μM (caesanamide A), 18.91 ± 0.98 μM (caesanamide B), and 7.82 ± 0.65 μM (caesanine B). Further flow cytometry analysis revealed that caesanine B could cause G0G1 cell cycle arrest and promote apoptosis in a dose- and time-dependent manner in HepG2 cells.
Collapse
Affiliation(s)
- Yue Jin
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China
| | - Miao Wang
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China
| | - Yan-Fang Yan
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China
| | - Xin-Xin Zhang
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China
| | - Xian-Zhe Li
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China
| | - Hui-Yuan Gao
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
| |
Collapse
|
4
|
Saha P, Rahman FI, Hussain F, Rahman SMA, Rahman MM. Antimicrobial Diterpenes: Recent Development From Natural Sources. Front Pharmacol 2022; 12:820312. [PMID: 35295739 PMCID: PMC8918777 DOI: 10.3389/fphar.2021.820312] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 12/30/2021] [Indexed: 12/12/2022] Open
Abstract
Antimicrobial resistance has been posing an alarming threat to the treatment of infectious diseases over the years. Ineffectiveness of the currently available synthetic and semisynthetic antibiotics has led the researchers to discover new molecules with potent antimicrobial activities. To overcome the emerging antimicrobial resistance, new antimicrobial compounds from natural sources might be appropriate. Secondary metabolites from natural sources could be prospective candidates in the development of new antimicrobial agents with high efficacy and less side effects. Among the natural secondary metabolites, diterpenoids are of crucial importance because of their broad spectrum of antimicrobial activity, which has put it in the center of research interest in recent years. The present work is aimed at reviewing recent literature regarding different classes of natural diterpenes and diterpenoids with significant antibacterial, antifungal, antiviral, and antiprotozoal activities along with their reported structure–activity relationships. This review has been carried out with a focus on relevant literature published in the last 5 years following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 229 diterpenoids from various sources like plants, marine species, and fungi are summarized in this systematic review, including their chemical structures, classification, and significant antimicrobial activities together with their reported mechanism of action and structure–activity relationships. The outcomes herein would provide researchers with new insights to find new credible leads and to work on their synthetic and semisynthetic derivatives to develop new antimicrobial agents.
Collapse
Affiliation(s)
- Poushali Saha
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Imtiaz Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Hussain
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
| | - S. M. Abdur Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
- *Correspondence: S. M. Abdur Rahman, ; M. Mukhlesur Rahman,
| | - M. Mukhlesur Rahman
- Medicines Research Group, School of Health, Sports and Bioscience, University of East London, London, United Kingdom
- *Correspondence: S. M. Abdur Rahman, ; M. Mukhlesur Rahman,
| |
Collapse
|
5
|
Syamsunarno MRA, Safitri R, Kamisah Y. Protective Effects of Caesalpinia sappan Linn. and Its Bioactive Compounds on Cardiovascular Organs. Front Pharmacol 2021; 12:725745. [PMID: 34603037 PMCID: PMC8479160 DOI: 10.3389/fphar.2021.725745] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 08/31/2021] [Indexed: 01/13/2023] Open
Abstract
Cardiovascular diseases are the leading cause of death worldwide. The long-term aim of cardiovascular disease therapy is to reduce the mortality rate and decelerate the progression of cardiovascular organ damage. Current therapies focus on recovering heart function and reducing risk factors such as hyperglycemia and dyslipidemia. However, oxidative stress and inflammation are important causes of further damage to cardiovascular organs. Caesalpinia sappan Linn. (Fabaceae), a flowering tree native to tropical Asia, has antioxidant and anti-inflammatory properties. It is used as a natural dye to color food and beverages and as a traditional treatment for diarrhea, diabetes, and blood stasis. The phytochemical compounds in C. sappan, mainly the homoisoflavonoids brazilin, sappanone A, protosappanin, and hematoxylin, can potentially be used to protect cardiovascular organs. This review aims to provide updates on recent developments in research on C. sappan in relation to treatment of cardiovascular diseases. Many studies have reported protective effects of the plant’s bioactive compounds that reduce cardiac damage and enhance vasorelaxation. For example, brazilin and sappanone A have an impact on molecular and cellular changes in cardiovascular disease pathogenesis, mainly by modulating oxidative, inflammatory, and apoptotic signaling pathways. Therefore, bioactive compounds of C. sappan have the potential to be developed as therapeutic agents to combat cardiovascular diseases like myocardial infarction and vascular disease. This review could help further the understanding of the possible modulatory role of the compounds in cardiovascular diseases, thereby facilitating future studies.
Collapse
Affiliation(s)
- Mas Rizky Aa Syamsunarno
- Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Jatinangor, Indonesia
| | - Ratu Safitri
- Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jatinangor, Indonesia
| | - Yusof Kamisah
- Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| |
Collapse
|
6
|
Holanda RJ, Deves C, Moreira-Dill LS, Guimarães CL, Marttinelli LKB, Fernandes CFC, Medeiros PSM, Pereira SS, Honda ER, Stábeli RG, Santos DS, Soares AM, Pereira da Silva LH. Plasmodium falciparum purine nucleoside phosphorylase as a model in the search for new inhibitors by high throughput screening. Int J Biol Macromol 2020; 165:1832-1841. [PMID: 33075341 DOI: 10.1016/j.ijbiomac.2020.10.062] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 09/28/2020] [Accepted: 10/09/2020] [Indexed: 10/23/2022]
Abstract
Studies have shown that inhibition of Plasmodium falciparum Purine Nucleoside Phosphorylase (PfPNP) blocks the purine salvage pathway in vitro and in vivo. In this study, PfPNP was evaluated as a model in the search for new inhibitors using surface plasmon resonance (SPR). Its expression, purification, oligomeric state, kinetic constants, calorimetric parameters and kinetic mechanisms were obtained. PfPNP was immobilized on a CM5 sensor chip and sensorgrams were produced through binding the enzyme to the substrate MESG and interactions between molecules contained in 10 fractions of natural extracts. The oligomeric state showed that recombinant PfPNP is a hexamer. The true steady-state kinetic parameters for the substrate inosine were: KM 17 μM, kcat 1.2 s-1, VMax 2.2 U/mg and kcat/KM 7 × 10-4; for MESG they were: KM 131 μM, kcat 2.4 s-1, VMax 4.4 U/mg and kcat/KM 1.8 × 10-4. The thermodynamic parameters for the substrate Phosphate were: ΔG - 5.8 cal mol-1, ΔH - 6.5 cal mol-1 and ΔS - 2.25 cal mol-1/degree. The ITC results demonstrated that the binding of phosphate to free PfPNP led to a significant change in heat and association constants and thermodynamic parameters. A sequential ordered mechanism was proposed as the kinetic mechanism. Three plant extracts contained molecules capable of interacting with PfPNP, showing different levels of affinity. The identification of plant extract fractions containing molecules that interact with recombinant PfPNP using SRP validates this target as a model in the search for new inhibitors. In this study, we showed for the first time the true steady-state kinetic parameters for reactions catalyzed by PfPNP and a model using PfPNP as a target for High-throughput Screening for new inhibitors through SPR. This knowledge will allow for the development of more efficient research methods in the search for new drugs against malaria.
Collapse
Affiliation(s)
- Rudson J Holanda
- Universidade Federal do Amazonas, UFAM, campus Humaitá, Amazonas, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil.
| | - Candida Deves
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Leandro S Moreira-Dill
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Cesar L Guimarães
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Leonardo K B Marttinelli
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Carla F C Fernandes
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Laboratório de Engenharia de Anticorpos, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil; Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Ceará, Fortaleza, Ceará, Brazil
| | - Patrícia S M Medeiros
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Soraya S Pereira
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Laboratório de Engenharia de Anticorpos, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil
| | - Eduardo R Honda
- Instituto de Pesquisa em Patologias Tropicais de Rondônia, IPEPATRO e Laboratório Central, LACEN, Porto Velho, Rondônia, Brazil
| | - Rodrigo G Stábeli
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Fundação Oswaldo Cruz, FIOCRUZ, Plataforma Bi-institucional de Medicina Translacional, Ribeirão Preto, São Paulo, Brazil
| | - Diógenes S Santos
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Centro Universitário São Lucas, UniSL, Porto Velho, Rondônia, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Brazil.
| | - Luiz H Pereira da Silva
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| |
Collapse
|
7
|
Yuanting J, Ruikang H, Yang L, Hanqiao L. Two new cassane-type diterpenoids from the seeds of Caesalpinia sappan. Nat Prod Res 2020; 36:2078-2084. [PMID: 33213201 DOI: 10.1080/14786419.2020.1849196] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
A new cassane diterpenoid, caesappine A (1), and a new natural cassane diterpenoid, caesappine B (2) were isolated from the seeds of Caesalpinia sappan. The new structures of compounds 1 and 2 were elucidated by analysing their 1D NMR, 2D NMR and HR-ESI-MS spectra. Compounds 1 and 2 were evaluated for the cytotoxic activities on Hela and HepG-2 human cancer cell lines.
Collapse
Affiliation(s)
- Jiang Yuanting
- Biochemical School, Beijing City University, Beijing, China
| | - Han Ruikang
- Biochemical School, Beijing City University, Beijing, China
| | - Liu Yang
- Biochemical School, Beijing City University, Beijing, China
| | - Liang Hanqiao
- Biochemical School, Beijing City University, Beijing, China
| |
Collapse
|
8
|
Wang M, Tan J, Chen J, Xie T, Lin LM, Zhong LL, Cai XJ, Wu QS. Three new ester glycosides with cytotoxic activity from the seeds of Caesalpinia sappan. Nat Prod Res 2020; 35:4409-4416. [PMID: 32272852 DOI: 10.1080/14786419.2020.1721488] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Three new ester glycosides, named as Caesateroside A (1), Caesateroside B (2) and Caesateroside C (3) were obtained from the seeds of Caesalpinia sappan. The new structures of compounds 1-3 were elucidated by analyzing their 1 D NMR, 2 D NMR and HR-ESI-MS spectra. Compounds 1-3 showed weak-moderate cytotoxicity against Hela and HepG-2 human cancer cell lines.
Collapse
Affiliation(s)
- Min Wang
- Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Juan Tan
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China
| | - Jun Chen
- Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Tian Xie
- Department of Respiratory and Critical Care Medicine, Hainan Genaral Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Liang-Mo Lin
- Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Li-Li Zhong
- Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Xing-Jun Cai
- Department of Respiratory and Critical Care Medicine, Hainan Genaral Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| | - Qiong-Shi Wu
- Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China
| |
Collapse
|
9
|
Jing W, Zhang X, Zhou H, Wang Y, Yang M, Long L, Gao H. Naturally occurring cassane diterpenoids (CAs) of Caesalpinia: A systematic review of its biosynthesis, chemistry and pharmacology. Fitoterapia 2019; 134:226-249. [DOI: 10.1016/j.fitote.2019.02.023] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2018] [Revised: 02/24/2019] [Accepted: 02/26/2019] [Indexed: 12/20/2022]
|
10
|
Hanson JR, Nichols T, Mukhrish Y, Bagley MC. Diterpenoids of terrestrial origin. Nat Prod Rep 2019; 36:1499-1512. [DOI: 10.1039/c8np00079d] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This review covers the isolation and chemistry of diterpenoids from terrestrial sources from 2017.
Collapse
Affiliation(s)
- James R. Hanson
- Department of Chemistry
- School of Life Sciences
- University of Sussex
- East Sussex
- UK
| | - Tyler Nichols
- Department of Chemistry
- School of Life Sciences
- University of Sussex
- East Sussex
- UK
| | - Yousef Mukhrish
- Department of Chemistry
- School of Life Sciences
- University of Sussex
- East Sussex
- UK
| | - Mark C. Bagley
- Department of Chemistry
- School of Life Sciences
- University of Sussex
- East Sussex
- UK
| |
Collapse
|